Research ArticleMolecular Imaging
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara and Buck E. Rogers
Journal of Nuclear Medicine January 2021, 62 (1) 137-143; DOI: https://doi.org/10.2967/jnumed.120.249557
Philipp Diebolder
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
2Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Cedric Mpoy
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
Jalen Scott
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
Truc T. Huynh
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
3Department of Chemistry, Washington University, St. Louis, Missouri; and
Ryan Fields
2Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
4Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Dirk Spitzer
2Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
4Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Nilantha Bandara
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
Buck E. Rogers
1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
4Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 1
January 1, 2021
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara, Buck E. Rogers
Journal of Nuclear Medicine Jan 2021, 62 (1) 137-143; DOI: 10.2967/jnumed.120.249557
Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara, Buck E. Rogers
Journal of Nuclear Medicine Jan 2021, 62 (1) 137-143; DOI: 10.2967/jnumed.120.249557
Jump to section
Related Articles
Cited By...
- No citing articles found.